“COST-EFFECTIVENESS ANALYSIS OF AUGMENTIN 625 MG AND AUCLANITYL 500 MG/125 MG IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA”, YHCĐ, vol. 67, no. 10, Nov. 2026, doi: 10.52163/yhc.v67i10.6965.